[
  {
    "ts": null,
    "headline": "Insulet promotes Eric Benjamin to chief operating officer",
    "summary": "As new CEO Ashley McEvoy lays the groundwork to build the brand globally, the diabetes tech company also hired Manoj Raghunandanan as chief growth officer.",
    "url": "https://finnhub.io/api/news?id=c87ae5fd9e05b290697205901f3e886981d1f5a43d345932e0d07a21f777b5a7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756221188,
      "headline": "Insulet promotes Eric Benjamin to chief operating officer",
      "id": 136530487,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PODD",
      "source": "Yahoo",
      "summary": "As new CEO Ashley McEvoy lays the groundwork to build the brand globally, the diabetes tech company also hired Manoj Raghunandanan as chief growth officer.",
      "url": "https://finnhub.io/api/news?id=c87ae5fd9e05b290697205901f3e886981d1f5a43d345932e0d07a21f777b5a7"
    }
  },
  {
    "ts": null,
    "headline": "Insulet Stock: Analyst Estimates & Ratings",
    "summary": "Insulet has significantly outpaced the broader market over the past year, and analysts remain very bullish on the stock’s prospects.",
    "url": "https://finnhub.io/api/news?id=855a0833c82a8252c122040aac47d78820ac1d3770adffb35d91364a491a24f7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756211646,
      "headline": "Insulet Stock: Analyst Estimates & Ratings",
      "id": 136530489,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PODD",
      "source": "Yahoo",
      "summary": "Insulet has significantly outpaced the broader market over the past year, and analysts remain very bullish on the stock’s prospects.",
      "url": "https://finnhub.io/api/news?id=855a0833c82a8252c122040aac47d78820ac1d3770adffb35d91364a491a24f7"
    }
  },
  {
    "ts": null,
    "headline": "Patient Monitoring Stocks Q2 Highlights: Insulet (NASDAQ:PODD)",
    "summary": "As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the patient monitoring industry, including Insulet (NASDAQ:PODD) and its peers.",
    "url": "https://finnhub.io/api/news?id=9b417e58fa369f6c4fd35e438f89cd9aa53ab341aecd42a0eee1278ce2f74cc4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756179344,
      "headline": "Patient Monitoring Stocks Q2 Highlights: Insulet (NASDAQ:PODD)",
      "id": 136526089,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PODD",
      "source": "Yahoo",
      "summary": "As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the patient monitoring industry, including Insulet (NASDAQ:PODD) and its peers.",
      "url": "https://finnhub.io/api/news?id=9b417e58fa369f6c4fd35e438f89cd9aa53ab341aecd42a0eee1278ce2f74cc4"
    }
  }
]